Safety Study of HSK55879 Tablet in Healthy Adults
This early-stage study tests how a new experimental medication (HSK55879) is tolerated and processed by the body in healthy volunteers. Researchers will also check how food affects the drug's absorption to help determine safe dosing for future patient studies.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be between 18 and 45 years old and in generally good health
- Weigh at least 50 kg (110 lbs) if male or 45 kg (99 lbs) if female
- Have a healthy body mass index (BMI) between 19.0 and 28.0
- Have no significant medical conditions affecting the stomach, liver, kidneys, or heart
- Agree not to plan pregnancy and use reliable contraception for 3 months after the study ends
- Pass screening blood tests, urine drug test, and infectious disease screening (hepatitis, HIV, syphilis)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new tablet called VV261 in healthy volunteers to see how safe it is and how the body processes it. It is an early study to gather important information before larger trials.
This trial tests a new medicine called HSK47388 to see if it is safe and how the body processes it. It is an early-stage study in healthy adults aged 18 to 55.
This is an early-stage safety test of a new investigational drug called HSK56630 in healthy volunteers with no major medical conditions. Researchers will monitor how your body tolerates the drug and what side effects might occur.
This trial is testing a new medicine called KHN707 in healthy people. The goal is to see if it is safe and how the body handles it. It is an early-stage study, so it is not intended to treat any condition yet.
This is an early-stage safety study testing a new experimental tablet called SYH2072 in healthy volunteers. Researchers will give increasing doses to understand how safe it is, how your body processes it, and what effects it has.
This study tests a new slow-release tablet (Hemay5259) in healthy people. It aims to check how safe the drug is, how it works in the body, and whether food changes its effects. Participants will receive the drug and be closely monitored for side effects.
Hear when a new Healhty trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.